Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Clinical Oncology

• Publication date

  1998-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.1998.16.4.1588PMID 9552070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.

  1997cited by this paper
• Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life

  1997cited by this paper
• Quality-of-life assessment in advanced cancer

  1996cited by this paper
• Kappa–opioids produce significantly greater analgesia in women than in men

  1996cited by this paper
• The impact of pain on quality of life. A decade of research.

  1995cited by this paper
• When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function

  1995cited by this paper
• Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee.

  1995cited by this paper
• The impact of pain on quality of life. A decade of research.

  1995cited by this paper
• Guidelines for the clinical use of transdermal fentanyl.

  1995cited by this paper
• Gender differences in the responses to noxious stimuli

  1995cited by this paper
• Measurement of the quality of life in cancer survivors

  1995cited by this paper
• Use of orally administered opioids for cancer-related pain.

  1994cited by this paper
• The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

  1994cited by this paper
• The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

  1993cited by this paper
• Quality of life: what is it? How should it be measured?

  1988cited by this paper

• High BMI predicts poor cancer pain relief when rotating from oral opioids to transdermal Fentanyl: a two-center retrospective study

  2025cites this paper
• Emerging Novel Psychoactive Substances (2020–2025): GC-MS Approaches for Separation, Detection, and Characterization

  2025cites this paper
• Developing a machine learning-based predictive model for the analgesic effectiveness of transdermal fentanyl in cancer patients: an interpretable approach

  2025cites this paper
• Transdermale Opioide bei chronischen Schmerzen richtig einsetzen

  2025cites this paper
• Determination of Fentanyl and Acetylfentanyl in Soil in Their Intact Form and Orthogonal Corroboration of Their Presence by EI-GC-MS Using Chloroformate Chemistry

  2023cites this paper
• Detection and confirmation of fentanyls in high clay‐content soil by electron ionization gas chromatography‐mass spectrometry

  2023cites this paper
• Transport of hydrocortisone in targeted layers of the skin by multi-lamellar liposomes

  2023cites this paper
• S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL

  2022cites this paper
• Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD)

  2021cites this paper
• Research progress on the potential novel analgesic BU08028.

  2021cites this paper
• Examining the Impacts of the Built Environment on Quality of Life in Cancer Patients Using Machine Learning

  2021cites this paper
• Palliative Care and Cancer Pain

  2021cites this paper
• Opioid Treatments for Chronic Pain

  2020cites this paper
• Fentanyl, Morphine, and Opioid-Induced Constipation in Patients with Cancer-Related Pain

  2020cites this paper
• Communication soignant-soigné : problématiques

  2019cites this paper
• Retrospective Review of the Use of Transdermal Buprenorphine Patches (Butrans) in a Pediatric Population

  2019cites this paper
• A Comparison of Drug Delivery into Skin Using Topical Solutions, Needle Injections and Jet Injections

  2019cites this paper
• Introduction & Literature Review

  2019cites this paper
• Discovery of Novel Biased Opioid Receptor Ligands through Structure‐Based Pharmacophore Virtual Screening and Experiment

  2019cites this paper
• Delivery Strategies for Skin: Comparison of Nanoliter Jets, Needles and Topical Solutions

  2019cites this paper
• Itopride increases the effectiveness of the management of opioid-induced constipation in palliative care patients: an observational non-interventional study

  2019cites this paper
• Sensitivity Enhancement for Direct Injection Capillary Electrophoresis to Determine Morphine in Human Serum via In-capillary Derivatization.

  2018cites this paper
• Preconditioning with hydrogen sulfide prevents bone cancer pain in rats through a proliferator-activated receptor gamma/p38/Jun N-terminal kinase pathway

  2018cites this paper
• Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl

  2018cites this paper
• Comparison of the effectiveness of fentanyl versus morphine for severe postoperative pain management. A randomized, double blind, clinical trial ☆

  2017cites this paper
• Recombinant protein transduction domain-Cu/Zn superoxide dismutase alleviates bone cancer pain via peroxiredoxin 4 modulation and antioxidation.

  2017cites this paper
• Comparación de la efectividad de fentanilo versus morfina en dolor severo postoperatorio. Ensayo clínico aleatorizado, doble ciego

  2017cites this paper
• Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review

  2017cites this paper
• Efficacy of fentanyl transdermal patch in pain control after lower third molar surgery: A preliminary study

  2016cites this paper
• Opioid Receptor Agonists and Antagonists

  2016cites this paper
• The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients

  2016cites this paper
• MHC-I promotes apoptosis of GABAergic interneurons in the spinal dorsal horn and contributes to cancer induced bone pain.

  2016cites this paper
• Long-term use of a once-a-day fentanyl citrate transdermal patch in lung cancer patients.

  2015cites this paper
• Pharmacological Management of Cancer-Related Pain.

  2015cites this paper
• Pain management in patients with opioid induced constipation – case report

  2015cites this paper
• ResearchEfficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population : a systematic review and meta-analysis

  2015cites this paper
• Managing opioid-induced constipation.

  2015cites this paper
• Assessing the response to opioids in cancer patients: a methodological proposal and the results

  2015cites this paper
• Use of the Low-Dose Buprenorphine Patch: Author Commentary

  2014cites this paper
• 37 – Minor and Short-Acting Analgesics, Including Opioid Combination Products

  2014cites this paper
• The use of opioid analgesics for chronic pain: minimizing the risk for harm.

  2014cites this paper
• [Use of fendivia transdermal therapeutic system in Russian patients with malignant neoplasms during palliative care: pharmacoeconomic aspects].

  2014cites this paper
• The effect of oil structure on the diffusion of solutes across synthetic membranes and human epidermis

  2014cites this paper
• Role of ATP-sensitive potassium channels in modulating nociception in rat model of bone cancer pain.

  2014cites this paper
• Constipation in palliative care patients – preliminary results of a cohort study

  2013cites this paper
• Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer

  2013cites this paper
• S3-Leitlinie zum exokrinen Pankreaskarzinom

  2013cites this paper
• Opioid-Induced Bowel Dysfunction

  2013cites this paper
• Transmucosal in addition to transdermal fentanyl, administered in exacerbations of cancer pain, does not change the emotional status of patients

  2013cites this paper
• Side Effects of Nociceptive Cancer Pain Treatments in Adults

  2013cites this paper
• Bone cancer pain: Causes, consequences, and therapeutic opportunities

  2013cites this paper
• Opioids for Chronic Orofacial Pain with a Focus on Nonmalignant Chronic Pain

  2013cites this paper
• Efficacy and safety of a six-hour continuous overlap method for converting intravenous to transdermal fentanyl in cancer pain.

  2013cites this paper
• A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults

  2012cites this paper
• Transdermal Matrix Fentanyl Membrane Patch (Matrifen®)

  2012cites this paper
• Perioperative care of the elderly oncology patient: A report from the SIOG task force on the perioperative care of older patients with cancer

  2012cites this paper
• Perioperative care of the elderly oncology patient: A report from the SIOG task force on the perioperative care of older patients with cancer

  2012cites this paper
• Transdermal Fentanyl

  2012cites this paper
• Reproducibility and validity of a satisfaction questionnaire on hypoglycemic agents: the Oral Hypoglycemic Agent Questionnaire (OHA-Q)

  2012cites this paper
• An exploratory analysis on the effectiveness of four strong opioids in patients with cancer pain.

  2012cites this paper
• Formulations of Fentanyl for the Management of Pain

  2012cites this paper
• A review of opioid prescription in a teaching hospital in Colombia

  2012cites this paper
• Opioid induced bowel dysfunction in cancer patients

  2012cites this paper
• Constipation – a difficult therapeutic problem

  2012cites this paper
• Sleep Characteristics in Patients with Whiplash-Associated Disorders: A Descriptive Study

  2012cites this paper
• Strategies for the Treatment of Cancer Pain in the New Millennium

  2012cites this paper
• Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 Chinese cancer patients

  2011cites this paper
• Oxidised Cellulose Gels and Films for Encapsulation and Release

  2011cites this paper
• A TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING DEFERIOXAMINE MESYLATE FOR THE TREATMENT OF BETA-THALASSAEMIA MAJOR

  2011cites this paper
• Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI‐20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self‐Report Questionnaire (MASQ)

  2011cites this paper
• Evaluation of efficacy and safety of fentanyl transdermal patch (Durogesic®D-TRANS) in chronic pain

  2010influential citation
• Palliative Therapie des fortgeschrittenen Pankreaskarzinoms

  2010cites this paper
• Efficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population: a systematic review and meta-analysis

  2010cites this paper
• The transdermal delivery of various anti–emetics

  2010cites this paper
• Psychotropic Drugs and Transdermal Delivery: An Overview

  2010cites this paper
• Sleep quality, the neglected outcome variable in clinical studies focusing on locomotor system; a construct validation study

  2010cites this paper
• Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch

  2010cites this paper
• Transdermal Opioids for Cancer Pain Management

  2010cites this paper
• Active methods for enhancing ( trans ) dermal drug delivery

  2009cites this paper
• Transdermal Fentanyl as A Front-Line Approach to Moderate-Severe Pain: A meta-analysis of Randomized Clinical Trials

  2009influential citation
• Adsorption properties of Crospovidone and use of Crospovidone in drug-in-adhesive patches

  2009cites this paper
• The role of transdermal fentanyl patches in the effective management of cancer pain.

  2009cites this paper
• Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep).

  2009cites this paper
• Treatment of peritoneal mesothelioma in pediatric patients

  2009cites this paper
• The Brief Pain Inventory User Guide

  2009cites this paper
• Pharmacology of opioid analgesia: Clinical principles

  2009cites this paper
• Gastrointestinal symptoms under opioid therapy: A prospective comparison of oral sustained‐release hydromorphone, transdermal fentanyl, and transdermal buprenorphine

  2009influential citation
• Symptom Management in Children with Cancer

  2009cites this paper
• Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation

  2009cites this paper
• Alzheimer’s disease treatment: Assessing caregiver preferences for mode of treatment delivery

  2009cites this paper
• Transdermal buprenorphine in children with cancer‐related pain

  2009cites this paper
• Comparison of Efficacy of Transdermal Fentanyl Patch in Treatment of Chronic Soft Tissue Cancer Pain With Placebo in A Double-Blind Randomized Clinical Trial

  2009cites this paper
• Recommandations pour la prévention et le traitement de la constipation induite par les opioïdes chez le patient relevant de soins palliatifs

  2009cites this paper
• Supportive Care for Older Cancer Patients

  2008cites this paper
• [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].

  2008cites this paper
• Adverse Effects of Transdermal Opiates Treating Moderate-Severe Cancer Pain in Comparison to Long-Acting Morphine: A Meta-Analysis and Systematic Review of the Literature

  2008cites this paper
• Use of Transdermal Drug Formulations in the Elderly

  2008cites this paper
• Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.

  2008cites this paper
• Chapitre 11 – Communication soignant-soigné: problématiques

  2008cites this paper
• Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)

  2008cites this paper